ADvance II Study: dBS-f in Patients With Mild Alzheimer's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The primary efficacy objective of this study is to test the hypothesis that DBS‐f stimulation (ON) will slow cognitive and functional progression of AD, as compared to no stimulation (OFF), by measuring baseline (pre‐implantation) to 12‐month change in the integrated Alzheimer's disease rating scale (iADRS).
Epistemonikos ID: 3ee946c8b6f666e23323eb354ef2ab6acd018012
First added on: May 21, 2024